Insiderhandel: President and Chief Scientific verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.940.376$
Yancopoulos, George - Vorstand - Tag der Transaktion: 2023-03-23...…
719,100€
1,21%
Echtzeit-Aktienkurs Regeneron Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie
Final Trades: Regeneron, Hess & Bank of America
The "Halftime Report" traders give their top picks to watch for the second half....…
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog....…
Regeneron, Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease....…
Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the Phase 3 trial of Dupixent (dupilumab), developed with Sanofi (NASDAQ: SNY), for uncontrolled chronic…
Regeneron draws more bullish views from analysts after Dupixent COPD data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron (REGN) Soars 6.8%: Is Further Upside Left in the Stock?
Regeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
Health Care Down as Sanofi, Regeneron Rise -- Health Care Roundup
Health Care Down as Sanofi, Regeneron Rise -- Health Care Roundup...…
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded…
Why Shares of Regeneron Are Rising Thursday
Regeneron released positive phase 3 trial results for its therapy Dupixent....…
Regeneron up 7% following Dupixent data, Raymond James upgrade
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move
Coinbase, Chewy, Regeneron, Accenture and First Republic were some of the most active shares on Thursday....…
Regeneron, Sanofi say Dupixent works in COPD
Shares of Regeneron Pharmaceuticals Inc. REGN rallied about 7% in premarket trading on Thursday after the company said a pivotal…
Sanofi erzielt Studienerfolg mit Dupixent bei COPD
Von Adria Calatayud PARIS (Dow Jones)--Sanofi hat einen Studienerfolg mit seinem gemeinsam mit Regeneron Pharmaceuticals entwickelten Medikament Dupixent zur…
Sanofi And Regeneron Say Phase 3 Study Of Dupixent To Treat COPD Meets Endpoints
PARIS (dpa-AFX) - Sanofi S.A. (SNYNF) and Regeneron Pharmaceuticals, Inc. (REGN) on Thursday said late-stage study of their Dupixent for…
Regeneron (REGN) Gets Label Extension for Cholesterol Drug
Regeneron (REGN) gets FDA approval for Evkeeza to treat children aged 5 to 11 with homozygous familial hypercholesterolemia....…
Regeneron: FDA Approves Evkeeza To Treat Ultra-rare Form Of High Cholesterol In Young Children
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) said that the U.S. Food and Drug Administration has approved Evkeeza (evinacumab-dgnb) to…
Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN
Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN...…
Regeneron (REGN) Gains But Lags Market: What You Should Know
Regeneron (REGN) closed the most recent trading day at $759.76, moving +0.07% from the previous trading session....…
Sanofi, Regeneron Dupixent gets approval in EU to treat eczema in kids over 6 months
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi/Regeneron say Dupixent skin treatment wins new regulatory approval in Europe
...PARIS, March 21 (Reuters) - Healthcare companies Sanofi
and Regeneron......…
Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last?
Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on…
Regeneron (REGN) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Regeneron (REGN) closed at $760.30, marking a -0.85% move from the previous day....…
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease
$250,000 top award goes to Neel Moudgal in the nations oldest and most prestigious science and math competition for high…
Regeneron Pharmaceuticals: Neues Kursziel
Toronto (www.aktiencheck.de) - Rating-Update:
Brian Abrahams, Analyst vom Investmenthaus RBC Capital Markets, belässt die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…
Regeneron Borrows From Big Pharma Playbook
Eylea, the companys top-selling blockbuster, isnt going away soon....…
Regeneron (REGN) Stock Moves -0.19%: What You Should Know
Regeneron (REGN) closed the most recent trading day at $743.75, moving -0.19% from the previous trading session....…
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Regeneron and Sarepta Therapeutics have been on fire so far this year....…
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review
Sanofis (SNY) sBLA seeking label expansion of drug Dupixent for chronic spontaneous urticaria accepted by the FDA...…
Regeneron wins EU nod for Libtayo in PD-L1 positive lung cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron: CHMP Backs Libtayo/Chemotherapy Combo in Advanced Non-Small Cell Lung Cancer
Regeneron: CHMP Backs Libtayo/Chemotherapy Combo in Advanced Non-Small Cell Lung Cancer...…
Regeneron Pharmaceuticals: Neues Kursziel
San Francisco (www.aktiencheck.de) - Rating-Update:
Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…
MARKETVUE® REPORT: Over 80% of U.S. gastroenterologists have prescribed Dupixent for Eosinophilic Esophagitis since its 2022 approval
First-to-market Regeneron/Sanofis Dupixent (dupilumab) sees strong uptake in Eosinophilic Esophagitis (EoE) since its May 2022 FDA approval, according to findings…
Regeneron Gets FDA Priority Review of Pozelimab in Chaple >REGN
Regeneron Gets FDA Priority Review of Pozelimab in Chaple >REGN...…
9 Healthcare Stocks That Fewer Bears Target
Cigna, Regeneron, Centene, and six other healthcare stocks have seen short interest drop by at least 40% recently. Fewer investors…
Regeneron wins FDA nod for Eylea to prevent infant blindness
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.890.400$
Goldstein, Joseph L. - Aufsichtsrat - Tag der Transaktion: 2023-02-06...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 795.359$
Bassler, Bonnie L. - Aufsichtsrat - Tag der Transaktion: 2023-02-03...…
Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 593.238$
Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-06...…
Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 564.966$
Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-03...…
Thinking about trading options or stock in Catalent, Tesla, IDEXX Laboratories, Exxon Mobil, or Regeneron Pharmaceuticals?
NEW YORK, Feb. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTLT, TSLA, IDXX, XOM, and REGN. Click…
Form 10-K REGENERON PHARMACEUTICAL For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 827.409$
Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-02-01...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 75.615$
Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-02-01...…
Dow & Co im Minus, Tech-Werte deutlich unter Druck: American Express, Apple, Regeneron und Tesla dennoch stark, Amazon, Home Depot und Microsoft schwach – der Tag an der Wall Street
Gewinnmitnahmen haben zum Wochenschluss die jüngste Rally der US-Technologiewerte ausgebremst. Für Ernüchterung sorgten enttäuschende Quartalsberichte zweier Schwergewichte der Tech-Branche. Hinzu…
Compared to Estimates, Regeneron (REGN) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Regeneron (REGN) give a sense of how the business performed in the quarter…
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Regeneron (REGN) tops earnings and sales estimates for the fourth quarter. However, sales of the lead drug Eylea decline year…
Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates
Regeneron (REGN) delivered earnings and revenue surprises of 29.75% and 7.84%, respectively, for the quarter ended December 2022. Do the…
Regeneron posts Q4 beat as COVID therapy offsets Eylea impact
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Pharma Q4 Profit Declines; Adj. Total Revenues Up 14%
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) reported fourth-quarter adjusted profit per share of $12.56 compared to $23.42, prior year.…